Wisconsin’s PBM Bill Amended, Advances from Senate Health Committee

September 9, 2025

EGWP marketplace medicaid Medicare

Wisconsin’s Senate Health Committee advanced a PBM reform bill (SB 203, known as Cole’s Act) following a key amendment to remove the bill’s dispensing fee provision. This change was prompted by fiscal concerns as the provision carried a projected cost of at least $20 million annually according to the state’s budget analysis.

Despite the removal of the dispensing fee, the bill retains several provisions that have drawn criticism from businesses and health plan sponsors. As currently written, the bill includes significant problems for businesses, clients, and patients, including restrictions on formulary changes, a PBM fiduciary duty standard, an any willing pharmacy requirement, a copay accumulator ban, and prohibits pharmacy fees and credentialing requirements. The bill now proceeds to the full Senate for consideration.

Initiatives

Calls grow for Drug Patent reform

In a recent blog post, the Pharmaceutical Care Management Association (PCMA) highlighted increased attention to pharmaceutical companies’ abuse of drug patents. Last month, the Supreme Court unanimously ruled in favor of a generic drugmaker in a “skinny labeling” case, a victory for patients. Skinny labels allow generic and biosimilar competitors to launch products for non-patented indications, helping accelerate […]
read more >

August 11, 2026

EGWP marketplace medicaid Medicare

perspectives

AHIP calls for Bipartisan reform to address health care cost drivers

On July 23, AHIP President and CEO Mike Tuffin wrote an opinion piece in The New York Times saying, “common-sense bipartisan reforms are needed to promote competition in care delivery and prescription drugs, protect consumers from providers and drugmakers’ anticompetitive practices and transition away from the perverse incentives of fee-for-service medicine.” Tuffin notes that health […]
read more >

August 11, 2026

EGWP marketplace medicaid Medicare

Solutions

PCMA urges preserving patient access and flexibility in new fertility benefits rule

PCMA recently submitted comments to HHS, DOL, and the Treasury (the Departments) in response to the proposed rule establishing a new category of limited excepted benefits for fertility services. PCMA supports the Departments’ goal of expanding access to fertility care while encouraging employer innovation but urged several targeted refinements to ensure the framework is operationally […]
read more >

August 11, 2026

marketplace medicaid

You may also like